Polymer- and liposome-based nanoparticles in targeted drug delivery.

This review focuses on polymer- and liposome-based nanoparticles used in targeted delivery of bioactive molecules, from drugs to siRNA to pDNA. The perspective centers around commercial and clinical successes, and a rationalization of these successes. Microparticulate systems are not covered, and only those applications that truly utilize the advantages of nano size are covered. "Stealth" systems dominate in this review, as most of the clinical successes are for passive targeting rather than for active targeting of tissue. The relevance of nano size to gene delivery is also discussed with relevant examples.

[1]  G. P. Agrawal,et al.  Nanoparticles as novel carrier for brain delivery: a review. , 2009, Current pharmaceutical design.

[2]  Joachim O. Rädler,et al.  Structure of DNA-Cationic Liposome Complexes: DNA Intercalation in Multilamellar Membranes in Distinct Interhelical Packing Regimes , 1997, Science.

[3]  V. Bloomfield,et al.  Condensation of DNA by multivalent cations: Considerations on mechanism , 1991, Biopolymers.

[4]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[5]  Feng Min,et al.  Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier. , 2005, International journal of pharmaceutics.

[6]  T. Okano,et al.  Development of the polymer micelle carrier system for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[7]  鈴木 健.  Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model , 2003 .

[8]  J. Feijen,et al.  Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell Uptake , 1999, Pharmaceutical Research.

[9]  S. Venkatraman,et al.  In Vitro Release of Complexed pDNA from Biodegradable Polymer Films , 2008 .

[10]  Yoshiaki,et al.  Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. , 1999, International journal of pharmaceutics.

[11]  M. Woodle,et al.  Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[12]  D. Mondal,et al.  Controlled release of complexed DNA from polycaprolactone film: comparison of lipoplex and polyplex release. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.

[13]  P Couvreur,et al.  Complement consumption by poly(ethylene glycol) in different conformations chemically coupled to poly(isobutyl 2-cyanoacrylate) nanoparticles. , 1997, Life sciences.

[14]  R. Müller,et al.  'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. , 2000, Colloids and surfaces. B, Biointerfaces.

[15]  R. Duncan,et al.  Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. , 1999, International journal of pharmaceutics.

[16]  H. Ueno,et al.  A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation , 2007, British Journal of Cancer.

[17]  R. Vile,et al.  Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[19]  Anil K Patri,et al.  Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.

[20]  D. A. Kharkevich,et al.  Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles , 1997, Pharmaceutical Research.

[21]  F. Szoka,et al.  Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. , 1979, Biochimica et biophysica acta.

[22]  A. Boddy,et al.  Phase I and pharmacokinetic study of NC-6004, a new platinum entity of cisplatin-conjugated polymer forming micelles , 2008 .

[23]  Feng Min,et al.  Micelle-like nanoparticles of star-branched PEO-PLA copolymers as chemotherapeutic carrier. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Andrew D. Miller,et al.  Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. , 2004, Biochemistry.

[25]  Y. Barenholz,et al.  Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. , 1993, Biochimica et biophysica acta.

[26]  R. Levy,et al.  Arterial uptake of biodegradable nanoparticles: effect of surface modifications. , 1998, Journal of pharmaceutical sciences.

[27]  D. Maysinger,et al.  Polycaprolactone-block-poly(ethylene oxide) micelles: a nanodelivery system for 17beta-estradiol. , 2005, Molecular pharmaceutics.

[28]  Hatem Fessi,et al.  Preparation and Characterization of Nanocapsules from Preformed Polymers by a New Process Based on Emulsification-Diffusion Technique , 1998, Pharmaceutical Research.

[29]  F. Boey,et al.  Release profiles in drug-eluting stents: issues and uncertainties. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Mary E. Russell,et al.  TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions , 2003, Circulation.

[31]  D. Lasič.  On the thermodynamic stability of liposomes , 1990 .

[32]  M. Radosz,et al.  Highly stable core-surface-crosslinked nanoparticles as cisplatin carriers for cancer chemotherapy. , 2006, Colloids and surfaces. B, Biointerfaces.

[33]  K. Kataoka,et al.  NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel , 2005, British Journal of Cancer.

[34]  S. Clerc,et al.  Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients. , 1995, Biochimica et biophysica acta.

[35]  J. Minna,et al.  Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  J. Minna,et al.  Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo , 2004, Cancer Gene Therapy.

[37]  R. Levy,et al.  Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles , 2000, Gene Therapy.

[38]  M. Bally,et al.  Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. , 1986, Biochimica et biophysica acta.

[39]  V. Torchilin,et al.  Micellar Nanocarriers: Pharmaceutical Perspectives , 2006, Pharmaceutical Research.

[40]  Martyn C. Davies,et al.  In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers , 1997 .

[41]  H. Ueno,et al.  Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin , 2004, British Journal of Cancer.

[42]  Vanessa Schmidt,et al.  Specific interactions improve the loading capacity of block copolymer micelles in aqueous media. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[43]  H. Strey,et al.  Improved DNA: liposome complexes for increased systemic delivery and gene expression , 1997, Nature Biotechnology.

[44]  Subbu S. Venkatraman,et al.  Block Copolymer ‘Stealth’ Nanoparticles for Chemotherapy: Interactions with Blood Cells In Vitro , 2008 .

[45]  J. Kos,et al.  Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: development and fundamental studies on preservation of its activity. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[46]  M. Newman,et al.  Comparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, pegylated liposomes (SPI-077) in tumor-bearing mice , 1999, Cancer Chemotherapy and Pharmacology.

[47]  Y. Sugiyama,et al.  Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. , 2003, Cancer research.

[48]  Michel Vert,et al.  Biodistribution of Long-Circulating PEG-Grafted Nanocapsules in Mice: Effects of PEG Chain Length and Density , 2001, Pharmaceutical Research.

[49]  E. Mayhew,et al.  Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes , 1993, Cancer.

[50]  F. Bressolle,et al.  Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review , 2004, Cancer Chemotherapy and Pharmacology.

[51]  Robert J. Levy,et al.  Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery , 1997 .

[52]  E J Topol,et al.  Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. , 1996, Circulation.